Puerto Rico

Manufacturing

PharmaEssentia Shores up Supply with $46M Investment in Puerto Rico Plant

The Taiwan-based company is establishing a manufacturing center for the U.S. market.

February 11, 2026

2 min read

Nick Paul Taylor

Businessman pushing boulder uphill vector concept of Sisyphus. Symbol of hard work, futile effort, strength, struggle, challenge but also motivation and ambition. Eps10 vector illustration.

Manufacturing

As Amgen and Lilly Recommit, Puerto Rico Seeks To Regain Manufacturing Momentum

After suffering in the wake of expired tax incentives for pharmas, the island is trying to take advantage of geopolitics to grow its drug manufacturing sector.

February 3, 2026

4 min read

Nick Paul Taylor

PRESS RELEASES

Press Releases

PharmaEssentia Announces Plans to Establish New U.S. Manufacturing Facility in Puerto Rico to Support Global Growth of BESREMi®

February 10, 2026

6 min read

Press Releases

Pharma-Bio Serv Announces Full Year Results and Special Dividend - January 29, 2026

January 30, 2026

3 min read

Press Releases

Adaptin Bio to Present at the 2026 Sequire Investor Summit in Puerto Rico

January 16, 2026

3 min read

Press Releases

Lilly announces more than $1.2 billion investment in Puerto Rico facility to boost oral medicine manufacturing capacity in the United States

October 30, 2025

6 min read

Press Releases

Aphaia Pharma Publishes Phase 1 and 2 Clinical Data of Oral Formulation in Patients with Obesity and Prediabetes

September 24, 2025

5 min read

Press Releases

Pharma-Bio Serv Announces Results for the Quarter Ended April 30, 2025

June 17, 2025

2 min read

Press Releases

Aspire Biopharma Holdings, Inc., Provides Development Update on BUZZ BOMB(TM), its New Sublingual Pre-Workout Supplement, Expected to Launch in Third Quarter of 2025

May 28, 2025

7 min read

Press Releases

IGC Pharma’s Puerto Rico CALMA Trial Site Offers Strategic Opportunity in High-Prevalence Alzheimer’s Market

May 23, 2025

4 min read

Press Releases

Aspire Biopharma Holdings, Inc., Announces First Patient Dosed in Phase 1 Clinical Trial for its Lead Program, an Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation

May 20, 2025

4 min read

Press Releases

Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference May 21

May 8, 2025

2 min read

Press Releases

Aspire Biopharma Holdings, Inc., Announces Institutional Review Board Approval for In-Human Clinical Trial of an Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation

April 30, 2025

5 min read

Press Releases

Aspire Biopharma Holdings, Inc., to Present at the Emerging Growth Conference on Thursday, April 17

April 14, 2025

3 min read

Press Releases

Aspire Biopharma Holdings, Inc., Announces Phase 1 Clinical Trial Initiation of its Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation

April 10, 2025

6 min read

Press Releases

Aspire Biopharma Holdings, Inc., Contract Manufacturer, Glatt Air Techniques, Inc., has Completed Its First Good Manufacturing Practice (“GMP”) Clinical Batch of Pharmaceutical Grade Oral Mucosal Fast Acting Formulation of Aspirin

March 20, 2025

5 min read

Press Releases

Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2025

March 18, 2025

2 min read

Press Releases

Aspire Biopharma Holdings, Inc., Provides Update on Recently Filed U.S. Patent Applications for Its Sublingual Drug Delivery Platform

March 13, 2025

6 min read

Press Releases

Aspire Biopharma Holdings, Inc., Provides an Update on Lead Product Candidate: High-Dose, Sublingual Aspirin

February 26, 2025

6 min read

Press Releases

Hemostemix PR Inc. Congratulates Luis Munoz Marin International Airport on Achieving CEIV Pharma Certification

February 11, 2025

6 min read

Press Releases

Pharma-Bio Serv Announces Full Year Results

January 30, 2025

3 min read

Press Releases

Pharma-Bio Serv Announces Special Dividend

January 30, 2025

2 min read